Category Archives: Pharma Industry Image

Purdue Pharma Settlement

The FDA announced this afternoon a settlement whereby Purdue Frederick Company, Inc. has agreed to pay more than $700 million to resolve criminal charges and civil liabilities in connection with several illegal schemes to promote, market and sell OxyContin – … Continue reading

Posted in Current Affairs, Pharma Industry Image | Comments Off on Purdue Pharma Settlement

State Status on HPV Mandates

Recently I have submitted posts regarding the executive order issued by Texas governor Rick Perry that mandated HPV vaccine Gardasil for teenage girls and on the Merck decision to pull back its lobbying program related to the same. The New … Continue reading

Posted in Current Affairs, Pharma Industry Image, Proposed Legislation | Comments Off on State Status on HPV Mandates

U-Turn on Gardasil Program – Balancing Product Promotion with Corporate Reputation

As we have all heard by now, Merck has decided to cease its lobbying efforts to promote its position that its HPV vaccine Gardasil should be mandatory for children. The HPV vaccine program has been fraught with controversy.  First, while … Continue reading

Posted in Pharma Industry Image | Comments Off on U-Turn on Gardasil Program – Balancing Product Promotion with Corporate Reputation

AIDS Perspectives and Values

TORONTO, ONTARIO – Today is my last day at the XVI International AIDS Conference.  In case you’ve been worried that you’ve been missing anything about FDA, I’ve kept tabs while I’ve been gone and so far, no speeches, no testimony … Continue reading

Posted in Current Affairs, Pharma Industry Image | Comments Off on AIDS Perspectives and Values

Prevention Pill Research – An HIV Opportunity for Pharma

From Toronto.  Last night, the XVI International AIDS Conference opened in Toronto, Ontario.  It is now a biennial conference and it is my sixth, having attended Florence, Amsterdam, Berlin, Vancouver and Geneva previously.  For what it is worth, like the … Continue reading

Posted in Clinical Trials, Current Affairs, Pharma Industry Image | 1 Comment